503b bulks list exclusion
How One Pharmacy Dodged 70% Semaglutide Exclusion Hits
Seventy percent of compounding mixes that contain semaglutide will be invalidated by the FDA’s 2024 bulk exclusion. I helped a pharmacy in Philadelphia rework its sourcing and documentation, allowing it to keep serving weight-loss patients despite the rule. Medical Disclaimer: This article is for informational purposes only and does